Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now includes a new entry 'Revision: v3.3.2' and removes the previous 'Revision: v3.3.1' entry.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page history shows a minor revision entry (Revision: v3.3.1) that appears to be a system or UI update and does not alter core study information or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe notice about government funding delays and operating status was removed from the page header. It previously informed users about potential delays and where to find status updates.SummaryDifference0.7%

- Check43 days agoChange DetectedA new version entry (Version 12, 2024-12-10) was added to the Record History, noting updates to Study Status and Outcome Measures.SummaryDifference0.1%

- Check71 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference12%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.